|
|
40
|
|
|
4181W
|
|
|
OCREVUS 300MG INJ (ROC/AHI) OCRELIZUMAB
|
|
|
OCRELIZUMAB
|
|
|
OCREVUS
|
|
|
10ML
|
|
|
C
|
|
|
17,533.1
|
|
|
17,533.1
|
|
|
300MG
|
|
|
INJECTION
|
|
|
0
|
|
|
VIAL
|
|
|
ROC
|
|
|
ROCHE SERVICIOS S.A.
|
|
|
AHI
|
|
|
ARMSTRONG HEALTHCARE INC
|
|
|
|
|
|
Anti-Neoplastic
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
No
|
|
|
1000
|
|
|
ANTINEOPLASTICS
|
|
|
|
|
|
IV
|
|
|
0
|
|
|
ANTINEOPLASTICS
|
|
|
|